Novo Nordisk, the Danish pharmaceutical giant, has announced an expansion of its partnership with U.S.-based tech firm Valo Health to develop new treatments for cardiometabolic diseases,...
Etiket: Zepbound
FDA Approves Eli Lilly’s Zepbound for Sleep Apnea, Expanding its Use in the U.S.
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s weight loss drug, Zepbound, for treating moderate-to-severe obstructive sleep apnea (OSA), the most common sleep-related...
Nestle Introduces Protein Shots to Target Weight-Loss Drug Users in the U.S.
Nestle (NESN.S), the world’s largest food company, has launched a new product in the United States aimed at weight-loss drug users: Boost Pre-Meal Hunger Support, a...